3-year overall survival in patients with resected non–small-cell lung can - Evidencio
3-year overall survival in patients with resected non–small-cell lung cancer
Because NSCLC is remarkably heterogeneous in regard to survival of individual patients, prediction of survival using the TNM staging system is imprecise. This postoperative nomogram was developed to predict 3-year overall survival of operable patients.
Research authors: Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, Wang Z, Zhu Z, Deng Q, Xiong X, Shao W, Shi X, He J.
Version: 1.10
  • Public
  • Oncology
  • {{ modelType }}
  • Details
  • Validate algorithm
  • Save input
  • Load input
Display
Units

{{ section.title }}

{{ section.description }}

Calculate the result

Set more parameters to perform the calculation

Predicted 3-year survival:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

How this model should be used: 
Liang et al (2015) established and validated a novel nomogram for predicting survival of patients with resected NSCLC.1 Through this model, clinicians could more precisely estimate the 3-year overall survival of individual patients after surgery and identify subgroups of patients who are in need of a specific treatment strategy.

Model performance: 
The calibration plots presented an excellent agreement in the primary cohort (N=5,261) and an acceptable agreement in the IASLC validation cohort (N=2,148) between the nomogram prediction and actual observation for 3-year overall survival (OS). The discriminative power (c-index) for the nomogram to predict OS (0.71; 95% CI, 0.70 to 0.72) was significantly higher than that of the TNM staging system (0.68; 95% CI, 0.67 to 0.69; P < 0.01). In the validation cohort, the reported c-index was 0.67 (95% CI, 0.65 to 0.69). 

Source: 
1 Liang W, Zhang L, Jiang G et al. Development and validation of a nomogram for predicting survival in patients with resectednon-small-cell lung cancer. J Clin Oncol. 2015;33(8):861-9.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying algorithms Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Algorithm feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits

With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Terms & Conditions | Privacy Policy | Disclaimer | Contact | Refuse cookies |
Evidencio v3.38 © 2015 - 2025 Evidencio. All Rights Reserved